Background. Respiratory viruses and Streptococcus pneumoniae are known to be copathogens in childhood pneumonia. However, it is unclear whether all pneumococcal serotypes are equally prone to such interaction. We attempted to determine association between carried pneumococcal serotypes and respiratory viruses during childhood community-acquired alveolar pneumonia (CAAP).
Respiratory viruses, mainly respiratory syncytial virus (RSV), are commonly detected in children with community-acquired pneumonia (CAP) infections, as well as bacteria [1] [2] [3] . The World Health Organization (WHO) published an expert group consensus stating that radiologically confirmed community-acquired alveolar pneumonia (CAAP) is of bacterial etiology in most cases, Streptococcus pneumoniae being the leading pathogen [4] [5] [6] . This definition has served as an endpoint in pneumococcal-conjugated vaccine (PCV) efficacy trials [7, 8] .
In children with radiologically confirmed pneumonia, S. pneumoniae nasopharyngeal bacterial loads were significantly higher in the presence of viral infection, mainly RSV, compared with those with no viral infection [9] . In addition, immunization with a 9-valent PCV (PCV9) resulted in a substantial reduction of virus-associated pneumonia hospital visits, and several studies have reported on reduction of hospitalization due to all-cause pneumonia based on International Classification of Diseases, Ninth Revision codes [10] and reductions in lower respiratory infections in infants and young children [11] [12] [13] . The interaction between respiratory viruses and S. pneumoniae resulting in pneumonia is complex and involves both direct (viral-bacterial interaction) and indirect interaction (through effect on the host) [14] [15] [16] .
Relative high invasiveness has been attributed to several pneumococcal serotypes during episodes of invasive disease, acute otitis media, and CAAP [17] [18] [19] . In most studies, serotypes 1, 5, and 7F showed a higher invasive potential for pneumonia, as well as infection in other sites (such as blood), compared with other serotypes [20, 21] . When adults with pneumococcal pneumonia were examined, among individuals with low levels of comorbidities, influenza virus had the largest impact on disease incidence among patients with low-invasive serotypes (3, 6A, 6B, 9N, 19F, 23F) compared with the high-invasive serotypes (1, 4, 7F, 9V, 18C), which suggests that S. pneumoniae with higher invasiveness may be more capable of causing pneumonia without the presence of a coinfecting virus [15] . Serotypes with relative higher invasiveness were carried significantly more frequently during pneumonia [19] and could be isolated from the patient's blood and pleural fluid. The same serotypes were isolated more frequently from pleural fluids and blood of children with CAP [22] .
The aims of this study were to examine the distribution of carried pneumococcal serotypes by children aged <5 years with CAAP and to compare the serotype distribution between those presenting with RSV coinfection, those with other common respiratory viruses, and those without codetected common respiratory viruses.
METHODS

Setting
The population of the region is composed of 2 ethnic groups: the Jewish population, generally comparable with a Western population, and the Bedouin Arab population, in transition from seminomadism to settlement, generally comparable with a developing population. The Bedouin population (approximately 166 000 in 2009) compared with the Jewish population (approximately 375 000), is characterized by overcrowding, lower education level, larger family size, and lower income [23] . Social contacts between these groups are limited, especially between children. However, both have access to the same medical services. Hospitalization rates for respiratory infectious diseases, especially for CAP, are higher among the Bedouin population [24] .
The Soroka University Medical Center is the only hospital in the Negev district of southern Israel providing primary and referral health services to the entire population of the southern region of Israel [25] , allowing population-based studies [26] . The 7-valent PCV (PCV7) was introduced into Israel's national immunization program in July 2009 and the 13-valent PCV (PCV13) in November 2010.
Study Design
This was a retrospective analysis of an ongoing prospective, population-based, observational study, conducted during an 8-year period from 2002 through 2009 (before the introduction of PCV to the national immunization program).
Children with the following criteria were included: (1) aged <60 months; (2) residents of the Negev region (southern Israel); (3) radiologically confirmed CAAP according to the WHO definitions [27] ; (4) nasopharyngeal (NP) culture for S. pneumoniae obtained within 24 hours of admission; (5) nasal wash (NPW) for respiratory viruses obtained within 48 hours of admission; and (6) informed consent signed by parents or legal guardian.
Exclusion Criteria
Children with any of the following criteria were excluded: (1) bleeding tendency precluding an NP sample; (2) a recurrent episode occurring <28 days after a previous included episode; and (3) pneumonia not confirmed as alveolar.
Chest Radiograph Analysis
All chest radiographs were analyzed as described previously [19] . In brief, alveolar pneumonia was determined according to the WHO definitions [19, 27] . All chest radiographs of children aged <5 years obtained at the pediatric emergency room (PER) or in the pediatric ward within the first 48 hours after admission were read daily by the 2 study pediatricians (D. G. and R. D.). For each case confirmed by 1 or both of the study pediatricians, a negative control case was matched (age, ethnic group, and date). The alleged cases and controls were sent to the study radiologist (J. B. Z.). A case was defined by a positive reading by at least 1 pediatrician followed by the confirmation of a pediatric radiologist [19] . Because only community-acquired cases were studied, all radiographs obtained ≥48 hours after admission were excluded.
Bacteriology
Nasopharyngeal samples were taken from patients during enrollment and processed as previously described [19] . Detection and identification of S. pneumoniae, including serotyping, was conducted as previously described [19] . Only 1 pneumococcal isolate per child was analyzed, unless the child had a mixed carriage with 2 different serotypes.
Virology
Nasopharyngeal wash specimens were requested from all children with CAAP during working hours, but not during weekends and holidays, and obtained from all those whose parents consented. Only 1 specimen from each patient was included. Specimens were processed for culture or polymerase chain reaction (PCR) diagnosis as described elsewhere [2] . Nasopharyngeal wash specimens, obtained using 2-5 mL of 0.9% saline solution with a mucus extractor kit were sent to the Clinical Virology Laboratory within 6 hours.
Until November 2006, the following diagnostic processes for viral detection were applied: RSV, influenza A and B viruses, parainfluenza virus, and adenovirus were detected first by direct immunofluorescence assay (DFA), using commercial monoclonal antibodies [28] . The specimens were also processed for viral cultures (Hep2, LLC, HF cells). After 14 days in culture (or befor if cytopathic effect was observed), DFA testing was repeated to maximize detection. Starting November 2006, all viral detection was by PCR. Human metapneumovirus was detected by PCR throughout the study. For RSV, a comparison showed <10% difference in detection rate by the DFA and culture followed by additional DFA method and PCR.
Data Analysis
Data were recorded using Microsoft Access office software. Statistical analysis was conducted using SPSS 21.0 software. Three groups were compared, according to the viral test results: Cases in which RSV was codetected with other viruses were excluded. To enable comparison between the groups, analysis was conducted only for cases enrolled during the RSV seasons (November-March).
We compared the prevalence of the various pneumococcal serotypes during pneumonia between the 3 study groups using a univariate analysis. The common invasive serotypes (1, 4, 5, 7F) were then grouped and compared with the most common noninvasive serotypes (15 B/C, 17F, 33F, 35B) in a multivariate analysis.
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for the 3 groups, adjusted for age, previous hospitalizations, and ethnicity. Children in the RSV(+) group were younger than children in the ORspVs(+) and RspVs (−) groups. The respective ages in months (± SD) were: 11.5 ± 12.1, 16.9 ± 13.9, and 20.6 ± 14.4 (Table 1) . No significant differences were detected between the groups with regard to sex, ethnicity, and number of siblings. Previous hospitalization was more frequent in the RspVs(−) group compared with the 2 other groups. A higher proportion of ORspVs(+) children were treated with antibiotics during the month preceding the CAAP episode compared with children in the 2 other groups. Prematurity was more common among children with RSV(+) CAAP compared with the 2 other groups. Temperature and oxygen saturation were significantly lower and the respiratory rate was significantly higher in the RSV(+) group compared with the 2 other groups. White blood cell counts, absolute neutrophil count, and C-reactive protein blood concentrations were higher in the RspVs(−) group compared with the RSV(+) and the ORspVs(+) groups. No significant differences were found in laboratory test results between the RSV(+) and ORspVs(+) groups.
Using univariate analysis, overall S. pneumoniae carriage rates were lower in the RSV(+) CAAP group than in the RspVs(−) and ORspVs(+) CAAP groups ( Table 2 ). The most frequent (number and percentage of all patients) serotypes in the study were: 14 (n = 82; 10.9%), 23F (n = 45; 6.0%), 19F (n = 45; 6.0%), 6B (n = 44; 5.8%), 6A (n = 34; 4.5%), and 19A (n = 32; 4.2%). The following serotypes were carried significantly more frequently among the RspVs(−) group than the RSV(+) group: serotypes 14 (13.8% vs 0.8%; P = .03), 1 (3.2% vs 0.8%; P = .047), and 7F (2.1% vs 0%; P = .03). Of the serotypes in Table 2 , serotypes 1, 4, 5, and 7F were previously described as invasive [21] . We therefore grouped them and calculated the odds ratio for carriage within the RSV(+) group versus the RspVs(−) group: the odds ratio for the invasive serotypes in RSV(+) versus RspVs(−) group was 0.18 (95% CI = .05-.60). In other words, patients with RespVs(−) carried these serotypes 5-fold compared with the RSV(+) group (Table 3) . Similar but nonsignificant trends were observed when the RSV(+) group was compared with the ORspVs(+) group (OR = 0.37; 95% CI = .08-1.70). (Table 3) , or when the ORspVs(+) group was compared with the RspVs(−) group (OR = 0.48; 95% CI = .18-1.28).
Of the common serotypes in Table 2 , serotypes 15B/C, 17F, 33F, and 35B were previously described to be of lesser virulence or called nonvirulent serotypes. [21] We therefore grouped them and calculated the OR for carriage (grouped) within the RSV(+) group versus the RspVs(−) group. The OR for carriage by the RSV(+) group compared with the RspVs(−) group was 2.39 (95% CI = .98-5.79; P = .054) ( Table 3) . Similar nonsignificant trends were seen when the RSV(+) group was compared with the ORspVs(+) group (OR = 1.73; 95% CI .56-5.37) (Table 3) , or when the ORspVs(+) group was compared with the RspVs(−) group (OR = 1.31; 95% CI = .39-4.42) ( Table 3) . Figure 1 presents the relationship between the frequencies of a given serotype in the RSV(+) group and the frequencies in the RspVs(−) group. More than 60% of the serotypes 15B/C, 17F, 33F, and 35B (grouped) were present in the RSV(+) group, whereas >85% of serotypes 1, 5, 4, and 7F (grouped) were present in in the RspVs(−) group virus.
DISCUSSION
It is widely accepted that CAAP is most frequently caused by pneumococcal infection [4, 5] . However, it is often difficult to determine its etiology and, in particular, the causative pneumococcal serotypes. Thus, nasopharyngeal carriage during CAAP can be used as an indirect epidemiological indication of pneumococcal serotype-related disease. Pneumonia can also be caused by coinfection of S. pneumoniae with other pathogens, mainly viruses. We aimed at determining whether certain serotypes (such as classical pneumonia serotypes vs less-invasive serotypes) are carried equally during CAAP with or without viral coinfection.
We found that during CAAP, the most invasive S. pneumoniae serotypes (namely, 1, 4, 5, and 7F) were carried significantly Statistically significant P values are indicated in bold.
Abbreviations: ORspVs(+), other respiratory viruses; RspVs(−), no respiratory virus; RSV(+), respiratory syncytial virus positive.
more frequently when no viral coinfection was detected than with viral coinfection, in particular those with RSV. In contrast, in patients with viral coinfection, carriage rates of the -invasive serotypes (namely, serotypes 33F, 17F, 15 B/C, and 35B) tended to be more frequent compared with patients with no detected respiratory virus. Pneumococcal disease is marked by a series of steps beginning with colonization of the nasopharynx and ending in either spread of the bacteria through the respiratory system to cause pneumonia or blood invasion. These steps are related to specific virulence factors produced by the bacteria [29] , the most important being the polysaccharide capsular serotypes [30] . Serotypes 1, 4, 5, and 7F were previously described to be the most invasive serotypes carried during alveolar pneumonia in children [31] . Respiratory syncytial virus was shown to directly increase pneumococcal virulence, especially in respiratory disease, through a number of mechanisms. Respiratory syncytial virus enhances adherence of S. pneumoniae to human epithelial cells by increasing binding to the extracellular domain where RSV G protein is expressed on the surface of the infected cells [31] . In addition, RSV increases virulence gene expression of pneumococci [14] . Respiratory syncytial virus infection can also increase bacterial proliferation [9] by modifying the innate immune responses [32, 33] and reduces cilia activity [14] .
From our findings and from what is currently known about the mechanisms used by RSV to augment the virulence of S. pneumoniae, it can be speculated that less-invasive serotypes do not typically cause disease unless a virus is present, whereas more invasive pneumonia serotypes may be sufficiently virulent to cause disease in relatively healthy children without the immunomodulation of the host by the virus. It may be speculated that the most invasive serotypes (1, 4, 5, and 7F) are also the most antibiotic-susceptible serotypes and thus could be affected by 1-3 antibiotic doses that had been possibly administered within the first 24 hours before culture was obtained. However, this risk was equal to cases with or without RSV.
Although as discussed herein, most CAAP cases may be of bacterial (mainly pneumococcal) origin, those with coinfection in this study exhibit some characteristics, such as lower temperature and peripheral overall lower white blood cell and neutrophil counts, that could be attributable to viral diseases. The finding of lower oxygen saturation and higher respiratory rates in children with coinfection also suggests a more widespread lung disease, which is typical of viral infections, rather than a localized infection, which is typical of pneumococcal CAAP. In a previous study, children aged <5 years hospitalized for CAAP had increased respiratory rates and reduced oxygen saturation when coinfections with a virus were detected than those with no coinfection: Respiratory rates were 61.5, 57.8, and 57.6 per minute in children with RSV, other viruses, and no viruses, respectively (P < .001 RSV vs the other groups). The respective proportions of children with oxygen saturations <92% were 54.1%, 46.6%. and 42.7% (P = .04 and P < .001 for RSV vs other viruses and RSV vs no viruses, respectively) [34] . However, no other evidence in the literature for such differences was found.
Our study has several limitations. First, in this study bacteria were not isolated directly from the lung, and diagnosis was made based on chest radiograph. In addition, the respiratory viruses were detected in a nasopharyngeal wash and not directly in a sample from the lung. However, chest radiography for the diagnosis of CAAP was a well-accepted diagnostic tool in other studies that demonstrated a reduction in CAAP after the introduction of PCV13, suggesting that these serotypes are frequently involved in CAAP cases [25] . Furthermore, nasopharyngeal sampling has been accepted as an indirect method of respiratory viral infection diagnosis [3] . Second, our subjects Serotypes (1, 4, 5, 7F ) Versus Most Commonly Carried "Noninvasive Serotypes (15B/C, 17F, 33F, 35B ) Among the 3 Study Groups: RSV(+) vs. RspVs(-) Groups (A); RSV(+) vs. were all hospitalized children, and it is possible that they do not represent the same spectrum of disease as that of ambulatory patients. Third, not all respiratory viruses were tested during the study period; however, the most common ones were included in this study. Fourth, because most of the CAAP in young children occurs during RSV season [16] , we chose to study the relationship of viral coinfections with pneumococcal serotypes during the RSV season, thus rendering the analysis of non-RSV respiratory viruses weakened, with fewer cases. This study demonstrates a possible interrelationship between some serotypes and coinfecting viruses during CAAP, mainly RSV in young children. We speculate that serotypes that are more invasive and have more predilection to the lung might more often cause disease independently of respiratory virus, whereas less-invasive serotypes possibly need enhancement by respiratory viruses (mostly RSV) to cause secondary bacterial infection. Our findings provide additional insight in the understanding of the interaction between respiratory viruses, especially RSV, and S. pneumoniae infection in the pathogenesis of pediatric CAAP.
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